MarketBeat Daily Ratings for Friday, February 28, 2025
Ratings changes for Super Micro Computer, PayPal, Materialise, Skye Bioscience, Skye Bioscience, Luna Innovations, Sandy Spring Bancorp and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. February 28th, 2025 | Elon’s “New Gold” (ad)MIT scientists just developed a brand-new metal…
A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology.
It’s so valuable that some are referring to it as the “new gold”.
I reveal all of the details here. |
|
Today's Top Stories | | By Gabriel Osorio-Mazilli | February 28, 2025 07:15 AM |
| | | By The Associated Press | February 27, 2025 09:57 PM |
| | By Thomas Hughes | February 28, 2025 06:26 AM |
| | | By The Associated Press | February 27, 2025 07:37 AM |
| | By Thomas Hughes | February 27, 2025 09:24 AM |
|
|
Analysts' Upgrades | | AAON (NASDAQ:AAON) was upgraded by analysts at CJS Securities from a "market perform" rating to an "outperform" rating. They now have a $110.00 price target on the stock. This represents a 49.0% upside from the current price of $73.82. | | Bath & Body Works (NYSE:BBWI) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $48.00 price target on the stock, up previously from $40.00. This represents a 33.3% upside from the current price of $36.02. | | CAVA Group (NYSE:CAVA) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $115.00 price target on the stock, down previously from $142.00. This represents a 25.6% upside from the current price of $91.55. | | Corebridge Financial (NYSE:CRBG) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $43.00 price target on the stock, up previously from $35.00. This represents a 25.1% upside from the current price of $34.37. | | OPENLANE (NYSE:KAR) was upgraded by analysts at Stephens from an "equal weight" rating to an "overweight" rating. They now have a $26.00 price target on the stock, up previously from $20.00. This represents a 17.2% upside from the current price of $22.19. | | Li Auto (NASDAQ:LI) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $40.00 price target on the stock, up previously from $22.00. This represents a 30.9% upside from the current price of $30.55. | | Nexstar Media Group (NASDAQ:NXST) was upgraded by analysts at Loop Capital from a "hold" rating to a "buy" rating. They now have a $200.00 price target on the stock. This represents a 16.9% upside from the current price of $171.11. | | PayPal (NASDAQ:PYPL) was upgraded by analysts at DZ Bank AG from a "hold" rating to a "buy" rating. They now have a $92.00 price target on the stock. This represents a 30.8% upside from the current price of $70.34. | | Rimini Street (NASDAQ:RMNI) was upgraded by analysts at Alliance Global Partners from a "neutral" rating to a "buy" rating.The current price is $3.41. | | Sprouts Farmers Market (NASDAQ:SFM) was upgraded by analysts at Northcoast Research from a "neutral" rating to a "buy" rating. They now have a $185.00 price target on the stock. This represents a 28.1% upside from the current price of $144.47. | | Energy Fuels (NYSEAMERICAN:UUUU) was upgraded by analysts at Roth Mkm from a "neutral" rating to a "buy" rating. They now have a $5.75 price target on the stock. This represents a 42.0% upside from the current price of $4.05. | | Vital Farms (NASDAQ:VITL) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $44.00 price target on the stock. This represents a 39.4% upside from the current price of $31.57. | | Voya Financial (NYSE:VOYA) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $87.00 price target on the stock, up previously from $76.00. This represents a 20.2% upside from the current price of $72.39. | | Welltower (NYSE:WELL) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $168.00 price target on the stock, up previously from $146.00. This represents a 10.2% upside from the current price of $152.39. |
|
View More Upgrades
|
Analysts' Downgrades | | Acadia Healthcare (NASDAQ:ACHC) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $35.00 price target on the stock, down previously from $43.00. This represents a 10.8% upside from the current price of $31.59. | | Alamo Group (NYSE:ALG) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $177.00 price target on the stock, down previously from $224.00. This represents a 1.3% downside from the current price of $179.39. | | Bentley Systems (NASDAQ:BSY) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $42.00 price target on the stock, down previously from $51.00. This represents a 3.1% downside from the current price of $43.37. | | DocGo (NASDAQ:DCGO) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating. They now have a $2.85 price target on the stock, down previously from $5.00. This represents a 1.9% downside from the current price of $2.91. | | Illumina (NASDAQ:ILMN) was downgraded by analysts at HSBC Holdings plc from a "buy" rating to a "hold" rating. They now have a $100.00 price target on the stock. This represents a 11.6% upside from the current price of $89.64. | | LeMaitre Vascular (NASDAQ:LMAT) was downgraded by analysts at Barrington Research from an "outperform" rating to a "market perform" rating.The current price is $92.16. | | LeMaitre Vascular (NASDAQ:LMAT) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.The current price is $92.16. | | Teleflex (NYSE:TFX) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $134.76. | | Teleflex (NYSE:TFX) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $155.00 price target on the stock, down previously from $220.00. This represents a 15.0% upside from the current price of $134.76. | | Tandem Diabetes Care (NASDAQ:TNDM) was downgraded by analysts at Sanford C. Bernstein from an "outperform" rating to a "market perform" rating. They now have a $25.00 price target on the stock, down previously from $35.00. This represents a 21.4% upside from the current price of $20.60. | | Vertex (NASDAQ:VERX) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $31.00 price target on the stock, down previously from $58.00. This represents a 5.3% downside from the current price of $32.73. | | Walgreens Boots Alliance (NASDAQ:WBA) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "sell" rating. They now have a $9.00 price target on the stock, down previously from $11.00. This represents a 15.8% downside from the current price of $10.69. | | WPP (NYSE:WPP) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating.The current price is $40.71. |
|
View More Downgrades
|
Analysts' New Coverage | | Altimmune (NASDAQ:ALT) is now covered by analysts at William Blair. They set a "market perform" rating on the stock.The current price is $6.29. | | Avalo Therapeutics (NASDAQ:AVTX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $48.00 price target on the stock. This represents a 606.4% upside from the current price of $6.80. | | (BIOA) (NYSE:BIOA) is now covered by analysts at William Blair. They set a "market perform" rating on the stock.The current price is $4.46. | | Corbus Pharmaceuticals (NASDAQ:CRBP) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $7.40. | | CoStar Group (NASDAQ:CSGP) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $89.00 price target on the stock. This represents a 19.5% upside from the current price of $74.49. | | Structure Therapeutics (NASDAQ:GPCR) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $23.13. | | Market Vectors Indian Rupee/USD ETN (NYSEARCA:INR) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $26.00 price target on the stock. This represents a 40.0% upside from the current price of $18.57. | | MediWound (NASDAQ:MDWD) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $39.00 price target on the stock. This represents a 137.9% upside from the current price of $16.40. | | Novavax (NASDAQ:NVAX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $19.00 price target on the stock. This represents a 148.0% upside from the current price of $7.66. | | Skye Bioscience (NASDAQ:SKYE) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $2.71. | | Summit Therapeutics (NASDAQ:SMMT) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $42.00 price target on the stock. This represents a 124.5% upside from the current price of $18.71. | | Terns Pharmaceuticals (NASDAQ:TERN) is now covered by analysts at William Blair. They set a "market perform" rating on the stock.The current price is $3.56. |
|
View More New Coverage
|
Calendars from MarketBeat | |
|
| Get 30 Days of MarketBeat All Access Free | | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. | | Start Your 30-Day Free Trial |
| Upgrade Your Subscription | | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | | Upgrade Now |
|
| Manage Your Watchlist | | View and add up to five holdings to your watchlist. | | View My Portfolio |
|
| Join Our Facebook Group | | Join MarketBeat’s free stock discussion and trading idea group on Facebook. | | Join Now |
|
Thank you for subscribing to MarketBeat!We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at [email protected].
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
© 2006-2025 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States. Today's Bonus Content: Apple-SpaceX Deal Sets Stage for Mode's Global Takeover |
